Genosis Share Discussion Threads

[monis] 16/4/2007 10:39

Can only buy £250 worth on line.

[monis] 16/4/2007 10:30

they have even got £2m in bank, way undervalued.

[bubsy2] 16/4/2007 10:29

online i think is shrinking fast

[monis] 16/4/2007 10:27

more buys going through.

[68steve] 16/4/2007 10:21

Online can only buy 1,500 shares@19p,could be some delayed buys(2hrs) or are they just short of stock....

[monis] 16/4/2007 10:16

The institutions would initially have bought in at at 110p. Bargin.

[68steve] 16/4/2007 10:09

Does look interesting + old and new investors want in,as good as ground floor also...

[lord santafe] 16/4/2007 09:47

All sounds very interesting and I am tempted to get some more before the big take off in price today.

For now I better go and tell my other friend before he miss's out on this opportunity.

[lord santafe] 16/4/2007 09:47

All sounds very interesting and I am tempted to get some more before the big take off in price today.

For now I better go and tell my other friend before he miss's out on this opportunity.

[monis] 16/4/2007 09:35

approx 70% of shares in issue seem held by institutions who would have bought a lot lot higher than these levels.

[lord santafe] 16/4/2007 09:22

30 minutes ago you could not sell more than 3,000 pounds worth online, and now you can sell over 5,000 pounds worth online.

This means we are about to rocket.

[monis] 16/4/2007 09:01

Selling Fertell through CVS is the first step of Genosis' US distribution
strategy.

[monis] 16/4/2007 08:37

LONDON (Thomson Financial) - Genosis PLC, a reproductive health products
company, said US drug store chain CVS, the largest in the US with over 6,000
stores nationwide, will sell Genosis' male and female over-the-counter fertility
test Fertell for the first time from May.
Financial details of the contract were not disclosed, but Genosis said the
test will typically retail for 99.99 usd.
Genosis expects additional distribution deals will be made with other chain
drug and retail stores for the Fertell product during this year.
Genosis said it plans to invest around 5 mln usd on its US marketing launch
campaign in 2007.

[lord santafe] 16/4/2007 08:34

still cheap for larger buys. My mate just got in at 18.2p.

[monis] 16/4/2007 08:31

they've even got £2m in the bank.

[monis] 16/4/2007 08:28

6000 stores $99 a unit, market cap for company £2m, these shares are cheap.

[lqs] 16/4/2007 08:19

Genosis PLC, AIM:(GNOS) a company focusing on consumer products for reproductive health, is pleased to announce that from this May, CVS, the largest drug store chain in the United States will be selling, for the first time, its male and female OTC fertility test Fertell.

CVS is the largest chain drug store in the US with over 6,000 stores across 43
states. Fertell will be sold through a combination of 'on shelf' product, shelf
cards promoting Fertell and at www.cvs.com. The Company has received an initial
order from CVS which will be delivered to the CVS regional distribution centres
in late April.

Full release:

[monis] 16/4/2007 08:16

Initial issue price 110p now have high street presence in US. Way undervalued.

[monis] 16/4/2007 08:12

This seems very undervalued.

[lqs] 16/4/2007 08:09

its a good one all right

[lord santafe] 16/4/2007 08:07

yes, decieded on this one now. I study all RNS each morning and this is the best one today so far.

[monis] 16/4/2007 08:03

Are you in?

[lord santafe] 16/4/2007 07:42

Could rise over 100% today if I buy in first thing?.

[lord santafe] 16/4/2007 07:42

Genosis Signs up Major US retailer


RNS Number:8715U
Genosis PLC
16 April 2007


For Immediate Release 16 April 2007


Genosis PLC


Signs up major US retailer CVS to sell its fertility test "Fertell"


"Genosis' first step into the US"



Genosis PLC, AIM:(GNOS) a company focusing on consumer products for reproductive
health, is pleased to announce that from this May, CVS, the largest drug store
chain in the United States will be selling, for the first time, its male and
female OTC fertility test Fertell.


CVS is the largest chain drug store in the US with over 6,000 stores across 43
states. Fertell will be sold through a combination of "on shelf" product, shelf
cards promoting Fertell and at www.cvs.com. The Company has received an initial
order from CVS which will be delivered to the CVS regional distribution centres
in late April.


Selling Fertell through CVS is the first step of Genosis' US distribution
strategy. Genosis anticipates that during this year, additional distribution
will be made with other chain drug and retail stores for them also to include
the Fertell product as part of their fertility merchandising programmes.


The Fertell couple test is ideally suited for the US market. Each year, in the
US, it is estimated that there are over three million couples aged 25 to 40 that
are trying to conceive. At-home fertility screening is an important and logical
first step for couples who want more information about their fertility status.
Fertell is the only FDA cleared OTC fertility test for couples and will
typically retail for $99.99.


Genosis plans to invest around $5 million on its US marketing launch campaign in
2007. US consumers will be alerted as to the availability and benefits of
Fertell through print advertising, web media and PR. In addition to selling
Fertell through chain drug stores the product is now available through
www.fertell.com.


In order to exploit and accelerate the opportunity in this highly significant US
market, the Directors' believe that further funds are required. These funds will
principally be utilised to support the marketing campaign of the Fertell product
in the US.


The Directors' are in the process of securing further financing and have already
received informal commitments from a number of institutions, including both
existing shareholders and new investors. An announcement will be made in the
near future with regards to this financing which will be conditional on the
approval of shareholders at an Extraordinary General Meeting and any necessary
regulatory approval. It is anticipated that a notice of EGM will be dispatched
to shareholders as soon as possible.



Paul Batemen, Chief Executive Officer said: "The introduction of the Fertell
product through CVS stores is a very significant milestone for the Company and a
strong reflection of the market opportunity for at-home fertility testing. This
fundraising will help us make the most of the sales potential for our innovative
product in the key US market."



For further details please contact:

Genosis PLC Paul Bateman, CEO [phone]
Jonathan Pockson, CFO

Buchanan Communications Lisa Baderoon [phone]
Rebecca Skye Dietrich








This information is provided by RNS
The company news service from the London Stock Exchange

END
MSCMGGMDNFMGNZM

[cerrito] 05/1/2007 16:19

never heard of them at 730but found myself buying some just after 9....not sure why as I have lost money in these kind of things in the past and indeed their accounts of getting the marketing structure for the US correct reminded me of Provalis....what swung me was the fact that they appear to have a good CFO, I found the RNS to be less BS free than of other companies and the rather irrelevant old chestnut thattheir marcap is almost covered by their 31.12.06 cash.
will take a look at CAR